Literature DB >> 25012021

Sellar and parasellar lesions - clinical outcome in 61 children.

Caroline Unsinn1, Marian Christoph Neidert2, Jan-Karl Burkhardt1, David Holzmann3, Michael Grotzer4, Oliver Bozinov5.   

Abstract

OBJECTIVE: To evaluate clinical outcome in a 10-year consecutive series of children operated for sellar and parasellar tumors with special focus on neuropsychology and endocrinology. PATIENTS AND METHODS: We analyzed 61 children (30 female) under 18 years of age (mean age 9.9, range 1 month-17 years) operated between 2000 and 2010. Medical records were evaluated retrospectively; postoperative histologic diagnoses included 20 craniopharyngiomas, 17 gliomas, 6 pituitary adenomas and 18 rare tumor entities.
RESULTS: Of 61 patients, 58 (95%) were still alive at last follow-up. Three patients died, all due to progression of malignant rhabdoid tumors. Postoperative clinical morbidity consisted of endocrinological (66%), visual (60.7%) and other neurological deficits (55.9%) after a mean follow-up of 44 months. When compared to all other tumor entities in this series, craniopharyngiomas were associated with high rates of gross-total resection (p=0.008), frequent progression of residual tumor (p=0.005) scotomas (p=0.013), persistent diabetes insipidus (p<0.001), and panhypopituitarism (p<0.001). Surgically treated gliomas showed higher rates of motor weakness (p=0.004), double vision (p<0.001), and milder forms of endocrinopathy (single hormone deficits, p=0.02). In general, deterioration in school performance was associated with multiple surgeries (p=0.018) and radiotherapy (p=0.021).
CONCLUSION: Excellent overall survival in these patients is possible, however malignant rhabdoid tumors have a poor prognosis. Aggressive treatment is associated with significant morbidity. Children operated for craniopharyngioma showed an expected high rate of endocrine deterioration, whereas glioma patients had higher incidences of motor weakness and double vision. The treating physicians should be well aware of all these considerable postoperative deficits, especially when facing interdisciplinary management decisions, and for the informed consent discussions with the patient and the parents.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Craniopharyngioma; Neurosurgery; Parasellar; Pediatrics; Sellar lesions

Mesh:

Year:  2014        PMID: 25012021     DOI: 10.1016/j.clineuro.2014.04.026

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

Review 1.  Visual function in children with primary brain tumors.

Authors:  Jason H Peragallo
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

2.  Pituitary incidentalomas in paediatric age are different from those described in adulthood.

Authors:  Pedro Souteiro; Rúben Maia; Rita Santos-Silva; Rita Figueiredo; Carla Costa; Sandra Belo; Cíntia Castro-Correia; Davide Carvalho; Manuel Fontoura
Journal:  Pituitary       Date:  2019-04       Impact factor: 4.107

3.  Risk factors associated with the surgical management of craniopharyngiomas in pediatric patients: analysis of 1961 patients from a national registry database.

Authors:  Joshua Bakhsheshian; Diana L Jin; Ki-Eun Chang; Ben A Strickland; Dan A Donoho; Steven Cen; William J Mack; Frank Attenello; Eisha A Christian; Gabriel Zada
Journal:  Neurosurg Focus       Date:  2016-12       Impact factor: 4.047

4.  Geographic-Related Differences of Pituitary Adenomas Hormone Profile: Analysis of Two Groups Coming from Southeastern and Eastern Europe.

Authors:  Anca Maria Cimpean; Eugen Melnic; Bogdan Bălinişteanu; Ana Corlan; Mihail Coculescu; Sergiu Rusu; Marius Raica
Journal:  Int J Endocrinol       Date:  2015-05-11       Impact factor: 3.257

Review 5.  Histopathology of Parasellar Neoplasms.

Authors:  Emilija Manojlovic-Gacic; Elham Rostami; Niki Karavitaki; Olivera Casar-Borota
Journal:  Neuroendocrinology       Date:  2020-03-11       Impact factor: 4.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.